| Financial Year |
March 31 2023 |
| Monetary Funds |
542,399,324.49 |
| Held-for-trading Financial Assets |
20,225,000.00 |
| Notes Receivable |
5,769,665.65 |
| Accounts Receivable |
460,910,149.16 |
| Advances to Suppliers |
4,991,416.76 |
| Other Receivables |
4,448,379.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
295,256,326.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
628,416,031.55 |
| Total Current Assets |
1,962,416,294.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
716,395,675.88 |
| Under-construction Projects |
584,036,298.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
103,503,297.29 |
| R&D expenses |
-- |
| Goodwill |
51,080,452.31 |
| Long-Term Deferred and Prepaid Expenses |
11,696,284.69 |
| Deferred Income Tax Assets |
33,180,426.92 |
| Other Non-Current Assets |
364,861,024.87 |
| Sub-Total of Non-Current Assets |
1,900,581,298.96 |
| Total Assets |
3,862,997,593.08 |
| Short-Term Loans |
958,739,939.87 |
| Trading Financial liabilities |
10,758,436.08 |
| Notes Payable |
100,174,937.14 |
| Accounts Payable |
521,005,730.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,844,794.36 |
| Taxes Payable |
8,184,817.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,992,719.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,526,493.36 |
| Other Current Liabilities |
131,692.21 |
| Sub-Total of Current Liabilities |
1,720,301,747.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
317,188.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,043,058.20 |
| Total Liabilities |
1,784,344,805.52 |
| Paid-In Capital(Or Share Stock) |
289,522,256.00 |
| Capital Surplus |
1,036,515,038.21 |
| Surplus Reserve |
63,648,635.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
691,544,331.05 |
| Minority Stockholder's Interest |
-2,577,472.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,081,230,260.46 |
| Owner's Equity（Stockholder's Equity） |
2,078,652,787.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,862,997,593.08 |
